GEO data analysis also confirmed that HIF1α expression was tightly correlated to pCR of taxane-based chemotherapy for BC patients, and IL-17-regulated gene CXC motif chemokine ligand 10 (CXCL10) was the only factor negatively relating to pCR after NAT. Here, IL17A is linked to breast cancer.